Hassan Hatoum
Title | Prof,Asst |
---|
Institution | University of Oklahoma Health Sciences Center |
---|
Department | Medicine Hematology/Oncology |
---|
Phone | 405/271-4022 |
---|
vCard | Download vCard |
---|
|
|
|
Biography Kursk State Medical University, Russia | MD | | Medicine | Staten Island University Hospital, Staten Island, NY | Resident | | Internal Medicine | Roswell Park Cancer Institute, Buffalo, NY | Fellow | | Hematology-Oncology |
Bibliographic
-
Iyer R, Hatoum H. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary. Clin Adv Hematol Oncol. 2016 May; 14(5 Suppl 7):17-9. PMID: 27168109.
-
Gupta N, Gupta S, Gandhi S, Hatoum H, Dy G. Critical acral ischaemia leading to multiple finger amputation: side-effect of long-term (>30 cycles) pemetrexed maintenance treatment in a patient. Br J Clin Pharmacol. 2014 Nov; 78(5):1167-8. PMID: 24962715; PMCID: PMC4243892.
-
Gupta N, Gupta S, Al Ustwani O, Pokuri V, Hatoum H, Bhat S. Bing-Neel syndrome in a patient with Waldenstrom's macroglobulinemia: a challenging diagnosis in the face of normal brain imaging. CNS Neurosci Ther. 2014 Oct; 20(10):945-6. PMID: 25102920.
-
Gupta N, Hatoum H, Dy GK. First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel. Int J Nanomedicine. 2014; 9:209-21. PMID: 24399877; PMCID: PMC3875520.
-
Harris K, Khachaturova I, Azab B, Maniatis T, Murukutla S, Chalhoub M, Hatoum H, Kilkenny T, Elsayegh D, Maroun R, Alkaied H. Small cell lung cancer doubling time and its effect on clinical presentation: a concise review. Clin Med Insights Oncol. 2012; 6:199-203. PMID: 22619563; PMCID: PMC3355865.
-
Farhat FS, Temraz S, Kattan J, Ibrahim K, Bitar N, Haddad N, Jalloul R, Hatoum HA, Nsouli G, Shamseddine AI. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer. Clin Breast Cancer. 2011 Dec; 11(6):384-9. PMID: 21993011.
-
Azab B, Torbey E, Hatoum H, Singh J, Khoueiry G, Bachir R, McGinn JT, McCord D, Lafferty J. Usefulness of red cell distribution width in predicting all-cause long-term mortality after non-ST-elevation myocardial infarction. Cardiology. 2011; 119(2):72-80. PMID: 21849785.
-
Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Indian J Surg Oncol. 2010 Dec; 1(4):305-12. PMID: 22695879; PMCID: PMC3372966.
-
El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A. Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives. Crit Rev Oncol Hematol. 2011 Dec; 80(3):433-49. PMID: 21330148.
-
Hatoum HA, Abi Saad GS, Otrock ZK, Barada KA, Shamseddine AI. Metastasis of colorectal carcinoma to the testes: clinical presentation and possible pathways. Int J Clin Oncol. 2011 Jun; 16(3):203-9. PMID: 21069550.
-
Otrock ZK, Hatoum HA, Musallam KM, Awada AH, Shamseddine AI. Is VEGF a predictive biomarker to anti-angiogenic therapy? Crit Rev Oncol Hematol. 2011 Aug; 79(2):103-11. PMID: 20724177.
-
Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Indian J Surg Oncol. 2010 Jan; 1(1):68-75. PMID: 22930621; PMCID: PMC3420989.
-
Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol. 2009 Dec; 16(12):3388-95. PMID: 19655200.
-
Musallam KM, Jamali FR, Hatoum HA, Seoud M, El-Saghir NS, Shamseddine AI. Axillary lymph node ratio revisited. J Clin Oncol. 2009 Aug 20; 27(24):e67; author reply e68-9. PMID: 19620478.
-
Kchour G, Tarhini M, Kooshyar MM, El Hajj H, Wattel E, Mahmoudi M, Hatoum H, Rahimi H, Maleki M, Rafatpanah H, Rezaee SA, Yazdi MT, Shirdel A, de Thé H, Hermine O, Farid R, Bazarbachi A. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood. 2009 Jun 25; 113(26):6528-32. PMID: 19411628.
-
Otrock ZK, Hatoum HA, Awada AH, Ishak RS, Shamseddine AI. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol. 2009 May; 70(2):93-102. PMID: 19186072.
-
Charafeddine KM, Hatoum HA, Otrock ZK, Mahfouz RA, Salem ZM, Shamseddine AI, Taher AT, El-Saghir NS, Bazarbachi A. Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut. Hematol Oncol Stem Cell Ther. 2009; 2(2):333-9. PMID: 20118056.
-
Farhat MH, Barada KA, Tawil AN, Itani DM, Hatoum HA, Shamseddine AI. Effect of mucin production on survival in colorectal cancer: a case-control study. World J Gastroenterol. 2008 Dec 07; 14(45):6981-5. PMID: 19058335; PMCID: PMC2773863.
-
Bazarbachi A, Hatoum H, Mugharbel A, Otrock Z, Yassine N, Muwakkit S, Salem Z, Shebbo W, Jisr T, Abboud M, Ibrahim A. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant. 2008 Aug; 42 Suppl 1:S96-S102. PMID: 18724316.
-
Hatoum HA, Habib JG, Tawil A, Chakhachiro Z, Otrock ZK, Husari A, Shamseddine A. Adenocarcinoma of the lung presenting as a metastatic tongue mass. South Med J. 2008 Jul; 101(7):770-1. PMID: 19209120.
-
Otrock ZK, Hatoum HA, Salem ZM, Tawil A, Mahfouz RA, Zaatari GS, Bazarbachi A. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation. Ann Hematol. 2008 Dec; 87(12):1023-4. PMID: 18587577.
-
El Kinge AR, Hatoum HA, Mahfouz RA, Otrock ZK, Jabbour E, Kantarjian H, Bazarbachi A. Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia. Leuk Res. 2009 Apr; 33(4):565-6. PMID: 18571231.
-
Otrock ZK, Hatoum HA, Uthman IW, Taher AT, Saab S, Shamseddine AI. Non-Hodgkin's lymphoma in a woman with adult-onset Still's disease: a case report. J Med Case Rep. 2008 Mar 06; 2:73. PMID: 18325097; PMCID: PMC2270857.
-
Otrock ZK, Hatoum HA, Salem ZM. Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma. Intern Emerg Med. 2008 Jun; 3(2):161-3. PMID: 18270789.
-
Hatoum HA, Mahfouz RA, Otrock ZK, Hudaib AR, Taher AT, Shamseddine AI. Acute myeloid leukemia with T-cell receptor gamma gene rearrangement occurring in a patient with chronic lymphocytic leukemia: a case report. Am J Hematol. 2007 Jan; 82(1):69-72. PMID: 16947317.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2007 | 1 | 2008 | 7 | 2009 | 5 | 2010 | 3 | 2011 | 4 | 2012 | 1 | 2013 | 1 | 2014 | 2 | 2016 | 1 |
To return to the timeline, click here.
|
Hatoum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|